Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.4000
-0.0300 (-6.98%)
Nov 18, 2025, 4:00 PM EST
Vireo Growth Market Cap
Vireo Growth has a market cap or net worth of $456.17 million as of November 19, 2025. Its market cap has increased by 362.48% in one year.
Market Cap
456.17M
Enterprise Value
561.18M
Revenue
189.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.40
Market Cap Chart
Since March 20, 2019, Vireo Growth's market cap has increased from 296.29M to 456.17M, an increase of 53.96%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 456.17M | 120.77% |
| Dec 31, 2024 | 206.63M | 498.26% |
| Dec 29, 2023 | 34.54M | 69.69% |
| Dec 30, 2022 | 20.35M | -90.69% |
| Dec 31, 2021 | 218.67M | 51.51% |
| Dec 31, 2020 | 144.33M | 59.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.30M |
| Elite Pharmaceuticals | 624.11M |
| Glass House Brands | 451.06M |
| CytoDyn | 396.27M |
| American Oncology Network | 369.77M |
| Northwest Biotherapeutics | 355.00M |
| Silence Therapeutics | 316.47M |
| Nika Pharmaceuticals | 311.89M |